Dexcom Inc. has been given approval for the first remote mobile communications device used for continuous glucose monitoring (CGM).
A leader in CGM, Dexcom were granted approval from the U.S Food and Drug Administration for the Dexcom SHARE device. This uses a wireless connection to transmit the glucose levels of a person with diabetes, which can be received on smartphones by up to five people.
These people, or “followers”, can remotely monitor this glucose information and receive the location of the person with diabetes and alert notifications on an Apple iPhone or iPod touch.
“Dexcom SHARE represents a significant advance in diabetes care by allowing people with diabetes to share important glucose information with their loved ones from afar,” explained Terrance H. Gregg, Chief Executive Officer of Dexcom Inc.
Dexcom SHARE uses Bluetooth technology and uploads data to a secure server, with the device hailed as a big development in diabetes care.
“The ability to share the continuous glucose data remotely, to almost any location, is a remarkable advance,” said Lori Laffel, M.D., M.P.H., Chief of the Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Centre, in Boston, MA.
Benefits to diabetes
The Dexcom SHARE allows parents and personal caregivers can monitor a childs or loved …read more
Source:: News from Diabetes.co.uk